Iris de Nie

144 APPPENDICES REFERENCES 1. WPATH. Standards of Care V7: The World Professional Association for Transgender Health; 2011. 2. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2017; 102 (11): 3869-903. 3. Tangpricha V, den Heijer M. Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol 2017; 5 (4): 291-300. 4. den Heijer M, Bakker A, Gooren L. Long term hormonal treatment for transgender people. BMJ 2017; 359 : j5027. 5. McFarlane T, Zajac JD, Cheung AS. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review. Clin Endocrinol (Oxf ) 2018; 89 (6): 700-11. 6. Dwyer AA, Quinton R. Anatomy and Physiology of the Hypothalamic-Pituitary-Gonadal (HPG) Axis. In: Llahana S, Follin C, Yedinak C, Grossman A, eds. Advanced Practice in Endocrinology Nursing. Cham: Springer International Publishing; 2019: 839-52. 7. Engebretsen L, Steffen K, Bahr R, et al. The International Olympic Committee Consensus Statement on age determination in high-level young athletes. Br J Sports Med 2010; 44 (7): 476-84. 8. Muciaccia B, Boitani C, Berloco BP, et al. Novel stage classification of human spermatogenesis based on acrosome development. Biol Reprod 2013; 89 (3): 60. 9. Johnson L, Petty CS, Neaves WB. A comparative study of daily sperm production and testicular composition in humans and rats. Biol Reprod 1980; 22 (5): 1233-43. 10. Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 2010; 16 (3): 231-45. 11. WHO.WHO laboratory manual for Examination and processing of human semen: World Health Organization; 2010. 12. van der Steeg JW, Steures P, Eijkemans MJ, et al. Role of semen analysis in subfertile couples. Fertil Steril 2011; 95 (3): 1013-9. 13. Hamilton JA, Cissen M, Brandes M, et al. Total motile sperm count: a better indicator for the severity of male factor infertility than the WHO sperm classification system. Hum Reprod 2015; 30 (5): 1110-21. 14. Hakenberg OW, Comperat EM, Minhas S, Necchi A, Protzel C, Watkin N. EAU guidelines on penile cancer: 2014 update. Eur Urol 2015; 67 (1): 142-50. 15. The Netherlands Comprehensive Cancer Organization (IKNL), Dutch Cancer Figures. 2017. https://embed.nkr -cijfers. nl/1.1.5/#/table?embedId=557&embedTitle=Incidence,%20Testis,%202017,%20Male,%20CR (accessed 7-8-2020. 16. Laguna MP, Albers, P. , Algaba, F. et al. EAU Guidelines on Testicular Cancer 2020. European Association of Urology. 17. Fenichel P, Chevalier N. Is Testicular Germ Cell Cancer Estrogen Dependent? The Role of Endocrine Disrupting Chemicals. Endocrinology 2019; 160 (12): 2981-9. 18. Giannandrea F, Paoli D, Figa-Talamanca I, Lombardo F, Lenzi A, Gandini L. Effect of endogenous and exogenous hormones on testicular cancer: the epidemiological evidence. Int J Dev Biol 2013; 57 (2-4): 255-63. 19. Skakkebaek NE, Rajpert-De Meyts E, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS 1998; 106 (1): 3-11; discussion 2. 20. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (5): E359-86. 21. Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2017; 71 (4): 618-29. 22. Nelson WG, De Marzo AM, Isaacs WB. Prostate Cancer. N Engl J Med 2003; 349 (4): 366-81. 23. Huggins C, Hodges CV. Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate. Cancer Res 1941; 1 (4): 293-7.